---
title: "The U.S. Securities and Exchange Commission (SEC) has filed charges against the former Chief Medical"
description: "The U.S. Securities and Exchange Commission (SEC) has filed charges against the former Chief Medical Officer of Fibrogen"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/256799980.md"
published_at: "2025-09-10T19:43:42.000Z"
---

# The U.S. Securities and Exchange Commission (SEC) has filed charges against the former Chief Medical

> The U.S. Securities and Exchange Commission (SEC) has filed charges against the former Chief Medical Officer of Fibrogen

The U.S. Securities and Exchange Commission (SEC) has filed charges against the former Chief Medical Officer of Fibrogen

### Related Stocks

- [FGEN.US - Fibrogen](https://longbridge.com/en/quote/FGEN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Metabiomed To Cancel 2.7 Billion Won Worth Of Own Shares | Metabiomed Co Ltd :METABIOMED: TO CANCEL 2.7 BILLION WON WORTH OF OWN SHARES | [Link](https://longbridge.com/en/news/276408478.md) |
| Ence To Cut 44 Jobs At Navia Biofactory By 2027 | Ence Energia y Celulosa SA :REACHES AGREEMENT ON COLLECTIVE DISMISSAL AT NAVIA BIOFACTORYAGREEMENT INCLUDES TERMINATION  | [Link](https://longbridge.com/en/news/276430844.md) |
| AgelessRx Expands Access to Multi-Cancer Early Detection Solutions, in Honor of Cancer Prevention Month | AgelessRx is expanding access to its multi-cancer early detection solutions in honor of Cancer Prevention Month. This in | [Link](https://longbridge.com/en/news/276180967.md) |
| US SEC Says Probe Involving Applovin Is 'Still Active And Ongoing' - Bloomberg News | US SEC SAYS PROBE INVOLVING APPLOVIN IS ‘STILL ACTIVE AND ONGOING’ - BLOOMBERG NEWS | [Link](https://longbridge.com/en/news/276478538.md) |
| Zynex Inc Says SEC Concluded Investigation Into Zynex, No Enforcement Action Planned | Zynex Inc :ZYNEX INC - SEC CONCLUDED INVESTIGATION INTO ZYNEX, NO ENFORCEMENT ACTION PLANNED - SEC FILING | [Link](https://longbridge.com/en/news/276385663.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
